{"transactions":[{"id":1221313,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-03-05T21:05:10.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":4869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on March 1, 2021."}],"balance_after":0,"derivative":{"exercise_price":8.22,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":4869},"source":{"system":"sec-edgar","filing":"0001415889-25-006919","document":"form4-03052025_040301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925006919/form4-03052025_040301.xml","form_type":"4"}},{"id":1221312,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:05:10.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":500,"price":33.2302,"value":16615.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.14 to $33.39. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-006919","document":"form4-03052025_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925006919/form4-03052025_040301.xml","form_type":"4"}},{"id":1221311,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:05:10.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":4369,"price":32.6103,"value":142474.4007,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.08 to $32.97. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001415889-25-006919","document":"form4-03052025_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925006919/form4-03052025_040301.xml","form_type":"4"}},{"id":1221310,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:05:10.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":4869,"price":8.22,"value":40023.18,"ownership":{"direct":true},"balance_after":4869,"source":{"system":"sec-edgar","filing":"0001415889-25-006919","document":"form4-03052025_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925006919/form4-03052025_040301.xml","form_type":"4"}},{"id":1292714,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-25","kind":"grant","planned":true,"acquired":true,"shares":13450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":13450,"derivative":{"underlying":"Common Stock","underlying_shares":13450},"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292713,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-25","kind":"grant","planned":true,"acquired":true,"shares":47200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":47200,"derivative":{"exercise_price":38.01,"expiration_date":"2035-01-25","underlying":"Common Stock","underlying_shares":47200},"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292712,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-24","kind":"exercise","planned":true,"acquired":false,"shares":2687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":8063,"derivative":{"underlying":"Common Stock","underlying_shares":2687},"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292711,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-24","kind":"exercise","planned":true,"acquired":false,"shares":13125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":39375,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":13125},"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292710,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-27","kind":"sale","planned":true,"acquired":false,"shares":1629,"price":38.024,"value":61941.096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.78 to $38.40. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292709,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":1058,"price":38.01,"value":40214.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1629,"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292708,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-24","kind":"exercise","planned":true,"acquired":true,"shares":2687,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2687,"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292707,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-24","kind":"sale","planned":true,"acquired":false,"shares":5125,"price":37.8737,"value":194102.7125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.485 to $38.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292706,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-24","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":36.9414,"value":295531.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.46 to $37.39. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5125,"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1292705,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T21:08:45.000Z","date":"2025-01-24","kind":"exercise","planned":true,"acquired":true,"shares":13125,"price":30.69,"value":402806.25,"ownership":{"direct":true},"balance_after":13125,"source":{"system":"sec-edgar","filing":"0001415889-25-002160","document":"form4-01282025_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002160/form4-01282025_090140.xml","form_type":"4"}},{"id":1298486,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-22T01:44:45.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":false,"shares":1123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023."}],"balance_after":5615,"derivative":{"exercise_price":33.44,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":1123},"source":{"system":"sec-edgar","filing":"0001415889-25-001825","document":"form4-01222025_010141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001825/form4-01222025_010141.xml","form_type":"4"}},{"id":1298485,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-22T01:44:45.000Z","date":"2025-01-16","kind":"exercise","planned":true,"acquired":false,"shares":29475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023."}],"balance_after":6738,"derivative":{"exercise_price":33.44,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":29475},"source":{"system":"sec-edgar","filing":"0001415889-25-001825","document":"form4-01222025_010141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001825/form4-01222025_010141.xml","form_type":"4"}},{"id":1298484,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-22T01:44:45.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":1123,"price":40,"value":44920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001825","document":"form4-01222025_010141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001825/form4-01222025_010141.xml","form_type":"4"}},{"id":1298483,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-22T01:44:45.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":true,"shares":1123,"price":33.44,"value":37553.12,"ownership":{"direct":true},"balance_after":1123,"source":{"system":"sec-edgar","filing":"0001415889-25-001825","document":"form4-01222025_010141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001825/form4-01222025_010141.xml","form_type":"4"}},{"id":1298482,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-22T01:44:45.000Z","date":"2025-01-16","kind":"sale","planned":true,"acquired":false,"shares":29475,"price":37.4146,"value":1102795.335,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.98. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001825","document":"form4-01222025_010141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001825/form4-01222025_010141.xml","form_type":"4"}},{"id":1298481,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-22T01:44:45.000Z","date":"2025-01-16","kind":"exercise","planned":true,"acquired":true,"shares":29475,"price":33.44,"value":985644.0,"ownership":{"direct":true},"balance_after":29475,"source":{"system":"sec-edgar","filing":"0001415889-25-001825","document":"form4-01222025_010141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001825/form4-01222025_010141.xml","form_type":"4"}},{"id":1301275,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-16T21:30:05.000Z","date":"2025-01-15","kind":"exercise","planned":true,"acquired":false,"shares":10507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023."}],"balance_after":36213,"derivative":{"exercise_price":33.44,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":10507},"source":{"system":"sec-edgar","filing":"0001415889-25-001549","document":"form4-01162025_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001549/form4-01162025_040101.xml","form_type":"4"}},{"id":1301274,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-16T21:30:05.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":10507,"price":37.0078,"value":388840.9546,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.08. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001549","document":"form4-01162025_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001549/form4-01162025_040101.xml","form_type":"4"}},{"id":1301273,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-16T21:30:05.000Z","date":"2025-01-15","kind":"exercise","planned":true,"acquired":true,"shares":10507,"price":33.44,"value":351354.08,"ownership":{"direct":true},"balance_after":10507,"source":{"system":"sec-edgar","filing":"0001415889-25-001549","document":"form4-01162025_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001549/form4-01162025_040101.xml","form_type":"4"}},{"id":1302230,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-01-15T21:30:31.000Z","date":"2025-01-13","kind":"exercise","planned":true,"acquired":false,"shares":7180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023."}],"balance_after":46720,"derivative":{"exercise_price":33.44,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":7180},"source":{"system":"sec-edgar","filing":"0001415889-25-001489","document":"form4-01152025_040125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001489/form4-01152025_040125.xml","form_type":"4"}},{"id":1302229,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-15T21:30:31.000Z","date":"2025-01-13","kind":"sale","planned":true,"acquired":false,"shares":7180,"price":37.0399,"value":265946.482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001489","document":"form4-01152025_040125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001489/form4-01152025_040125.xml","form_type":"4"}},{"id":1302228,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-15T21:30:31.000Z","date":"2025-01-13","kind":"exercise","planned":true,"acquired":true,"shares":7180,"price":33.44,"value":240099.2,"ownership":{"direct":true},"balance_after":7180,"source":{"system":"sec-edgar","filing":"0001415889-25-001489","document":"form4-01152025_040125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925001489/form4-01152025_040125.xml","form_type":"4"}},{"id":1378728,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-10-31T20:45:38.000Z","date":"2024-10-29","kind":"exercise","planned":true,"acquired":false,"shares":21496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on August 21, 2021."}],"balance_after":28972,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":21496},"source":{"system":"sec-edgar","filing":"0001415889-24-025826","document":"form4-10312024_081034.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924025826/form4-10312024_081034.xml","form_type":"4"}},{"id":1378727,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-31T20:45:38.000Z","date":"2024-10-29","kind":"sale","planned":true,"acquired":false,"shares":21496,"price":40.4735,"value":870018.356,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.94. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-025826","document":"form4-10312024_081034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924025826/form4-10312024_081034.xml","form_type":"4"}},{"id":1378726,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-31T20:45:38.000Z","date":"2024-10-29","kind":"exercise","planned":true,"acquired":true,"shares":21496,"price":24,"value":515904.0,"ownership":{"direct":true},"balance_after":21496,"source":{"system":"sec-edgar","filing":"0001415889-24-025826","document":"form4-10312024_081034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924025826/form4-10312024_081034.xml","form_type":"4"}},{"id":1389887,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-07T20:04:22.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":705,"price":35.6191,"value":25111.4655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.59 to $35.69. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-024813","document":"form4-10072024_081018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024813/form4-10072024_081018.xml","form_type":"4"}},{"id":1389886,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-07T20:04:22.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":35652,"price":35.0453,"value":1249435.0356,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.58 to $35.57. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":705,"source":{"system":"sec-edgar","filing":"0001415889-24-024813","document":"form4-10072024_081018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024813/form4-10072024_081018.xml","form_type":"4"}},{"id":1393602,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-10-02T20:06:11.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five qual annual installments beginning on August 21, 2021."}],"balance_after":50468,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001415889-24-024377","document":"form4-10022024_081008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024377/form4-10022024_081008.xml","form_type":"4"}},{"id":1393601,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:06:11.000Z","date":"2024-10-01","kind":"sale","planned":false,"acquired":false,"shares":400,"price":40.1923,"value":16076.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.45. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-024377","document":"form4-10022024_081008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024377/form4-10022024_081008.xml","form_type":"4"}},{"id":1393600,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:06:11.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":true,"shares":400,"price":24,"value":9600.0,"ownership":{"direct":true},"balance_after":400,"source":{"system":"sec-edgar","filing":"0001415889-24-024377","document":"form4-10022024_081008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024377/form4-10022024_081008.xml","form_type":"4"}},{"id":1393598,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-10-02T20:05:20.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":90000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-024364","document":"form4-10022024_081008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024364/form4-10022024_081008.xml","form_type":"4"}},{"id":1393597,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:05:20.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":23643,"price":40,"value":945720.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":36357,"source":{"system":"sec-edgar","filing":"0001415889-24-024364","document":"form4-10022024_081008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024364/form4-10022024_081008.xml","form_type":"4"}},{"id":1393596,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:05:20.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001415889-24-024364","document":"form4-10022024_081008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024364/form4-10022024_081008.xml","form_type":"4"}},{"id":1396472,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-10-01T20:07:54.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":35846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five qual annual installments beginning on August 21, 2021."}],"balance_after":50868,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":35846},"source":{"system":"sec-edgar","filing":"0001415889-24-024179","document":"form4-10012024_081050.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024179/form4-10012024_081050.xml","form_type":"4"}},{"id":1396471,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-01T20:07:54.000Z","date":"2024-09-30","kind":"sale","planned":false,"acquired":false,"shares":35846,"price":40.031,"value":1434951.226,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.19. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-024179","document":"form4-10012024_081050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024179/form4-10012024_081050.xml","form_type":"4"}},{"id":1396470,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-01T20:07:54.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":35846,"price":24,"value":860304.0,"ownership":{"direct":true},"balance_after":35846,"source":{"system":"sec-edgar","filing":"0001415889-24-024179","document":"form4-10012024_081050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024179/form4-10012024_081050.xml","form_type":"4"}},{"id":1397718,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-09-30T20:03:15.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on August 21, 2021."}],"balance_after":86714,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-24-024089","document":"form4-09302024_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024089/form4-09302024_080911.xml","form_type":"4"}},{"id":1397717,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-30T20:03:15.000Z","date":"2024-09-27","kind":"sale","planned":false,"acquired":false,"shares":200,"price":40.045,"value":8009.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-024089","document":"form4-09302024_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024089/form4-09302024_080911.xml","form_type":"4"}},{"id":1397716,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-30T20:03:15.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":true,"shares":200,"price":24,"value":4800.0,"ownership":{"direct":true},"balance_after":200,"source":{"system":"sec-edgar","filing":"0001415889-24-024089","document":"form4-09302024_080911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924024089/form4-09302024_080911.xml","form_type":"4"}},{"id":1571751,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-03-18T23:24:20.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":9644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on March 1, 2021."}],"balance_after":4869,"derivative":{"exercise_price":8.22,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":9644},"source":{"system":"sec-edgar","filing":"0001415889-24-008350","document":"form4-03182024_110312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924008350/form4-03182024_110312.xml","form_type":"4"}},{"id":1571750,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-03-18T23:24:20.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":2335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on October 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":8.22,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":2335},"source":{"system":"sec-edgar","filing":"0001415889-24-008350","document":"form4-03182024_110312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924008350/form4-03182024_110312.xml","form_type":"4"}},{"id":1571749,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-18T23:24:20.000Z","date":"2024-03-15","kind":"sale","planned":false,"acquired":false,"shares":11979,"price":32,"value":383328.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.06. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-008350","document":"form4-03182024_110312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924008350/form4-03182024_110312.xml","form_type":"4"}},{"id":1571748,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-18T23:24:20.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":true,"shares":11979,"price":8.22,"value":98467.38,"ownership":{"direct":true},"balance_after":11979,"source":{"system":"sec-edgar","filing":"0001415889-24-008350","document":"form4-03182024_110312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924008350/form4-03182024_110312.xml","form_type":"4"}},{"id":1583445,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-03-11T21:17:32.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":94,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on March 1, 2021."}],"balance_after":14513,"derivative":{"exercise_price":8.22,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":94},"source":{"system":"sec-edgar","filing":"0001415889-24-007527","document":"form4-03112024_090322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924007527/form4-03112024_090322.xml","form_type":"4"}},{"id":1583444,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-03-11T21:17:32.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on October 1, 2019."}],"balance_after":2335,"derivative":{"exercise_price":8.22,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001415889-24-007527","document":"form4-03112024_090322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924007527/form4-03112024_090322.xml","form_type":"4"}},{"id":1583443,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-11T21:17:32.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":194,"price":32,"value":6208.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in a single transaction at a selling price of $32.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-007527","document":"form4-03112024_090322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924007527/form4-03112024_090322.xml","form_type":"4"}},{"id":1583442,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-11T21:17:32.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":194,"price":8.22,"value":1594.68,"ownership":{"direct":true},"balance_after":194,"source":{"system":"sec-edgar","filing":"0001415889-24-007527","document":"form4-03112024_090322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924007527/form4-03112024_090322.xml","form_type":"4"}},{"id":1669183,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T21:55:32.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":10750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units were granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":10750,"derivative":{"underlying":"Common Stock","underlying_shares":10750},"source":{"system":"sec-edgar","filing":"0001415889-24-001871","document":"form4-01262024_090124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924001871/form4-01262024_090124.xml","form_type":"4"}},{"id":1669182,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-01-26T21:55:32.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":52500,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001415889-24-001871","document":"form4-01262024_090124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924001871/form4-01262024_090124.xml","form_type":"4"}},{"id":1746456,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-11-08T21:02:09.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":150000,"derivative":{"exercise_price":31.78,"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-23-014890","document":"form4-11082023_091102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588923014890/form4-11082023_091102.xml","form_type":"4"}},{"id":2143499,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2022-10-04T20:07:24.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":2434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in five equal annual installments beginning on October 1, 2019."}],"balance_after":2435,"derivative":{"exercise_price":8.22,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":2434},"source":{"system":"sec-edgar","filing":"0001415889-22-010215","document":"form4-10042022_011050.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922010215/form4-10042022_011050.xml","form_type":"4"}},{"id":2143498,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2022-10-04T20:07:24.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":9739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on October 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":9739},"source":{"system":"sec-edgar","filing":"0001415889-22-010215","document":"form4-10042022_011050.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922010215/form4-10042022_011050.xml","form_type":"4"}},{"id":2143497,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-10-04T20:07:24.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":2791,"price":45.472,"value":126912.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.97 to $45.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-010215","document":"form4-10042022_011050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922010215/form4-10042022_011050.xml","form_type":"4"}},{"id":2143496,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-10-04T20:07:24.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":9382,"price":44.4472,"value":417003.6304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.93 to $44.91. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2791,"source":{"system":"sec-edgar","filing":"0001415889-22-010215","document":"form4-10042022_011050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922010215/form4-10042022_011050.xml","form_type":"4"}},{"id":2143495,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-10-04T20:07:24.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":12173,"price":8.22,"value":100062.06,"ownership":{"direct":true},"balance_after":12173,"source":{"system":"sec-edgar","filing":"0001415889-22-010215","document":"form4-10042022_011050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922010215/form4-10042022_011050.xml","form_type":"4"}},{"id":2175715,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2022-08-23T20:11:06.000Z","date":"2022-08-22","kind":"exercise","acquired":false,"shares":28971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on August 21, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The Form 4 filed by the reporting person on March 2, 2022, overstated the number of securities owned following the reported transaction by 200 shares.  The amount of securities reported herein reflects the correct number of securities owned following the transactions reported on this Form 4."}],"balance_after":86914,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":28971},"source":{"system":"sec-edgar","filing":"0001415889-22-008969","document":"form4-08232022_010849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008969/form4-08232022_010849.xml","form_type":"4"}},{"id":2175714,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-23T20:11:06.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":2321,"price":47.5637,"value":110395.3477,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.41 to $47.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-008969","document":"form4-08232022_010849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008969/form4-08232022_010849.xml","form_type":"4"}},{"id":2175713,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-23T20:11:06.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":26650,"price":46.9543,"value":1251332.095,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $47.39. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2321,"source":{"system":"sec-edgar","filing":"0001415889-22-008969","document":"form4-08232022_010849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008969/form4-08232022_010849.xml","form_type":"4"}},{"id":2175712,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-23T20:11:06.000Z","date":"2022-08-22","kind":"exercise","acquired":true,"shares":28971,"price":24,"value":695304.0,"ownership":{"direct":true},"balance_after":28971,"source":{"system":"sec-edgar","filing":"0001415889-22-008969","document":"form4-08232022_010849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008969/form4-08232022_010849.xml","form_type":"4"}},{"id":2303234,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-04-05T21:07:48.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":14471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on August 21, 2021."}],"balance_after":116085,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":14471},"source":{"system":"sec-edgar","filing":"0001104659-22-042846","document":"tm2211710-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922042846/tm2211710-1_4seq1.xml","form_type":"4"}},{"id":2303233,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T21:07:48.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":7706,"price":49.8673,"value":384277.4138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.69 to $50.02. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-042846","document":"tm2211710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922042846/tm2211710-1_4seq1.xml","form_type":"4"}},{"id":2303232,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T21:07:48.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":6765,"price":49.3559,"value":333892.6635,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.69 to $49.68. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7706,"source":{"system":"sec-edgar","filing":"0001104659-22-042846","document":"tm2211710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922042846/tm2211710-1_4seq1.xml","form_type":"4"}},{"id":2303231,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T21:07:48.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":14471,"price":24,"value":347304.0,"ownership":{"direct":true},"balance_after":14471,"source":{"system":"sec-edgar","filing":"0001104659-22-042846","document":"tm2211710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922042846/tm2211710-1_4seq1.xml","form_type":"4"}},{"id":2359190,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-03-02T21:05:45.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":4869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in five equal annual installments beginning on March 4, 2021"}],"balance_after":14607,"derivative":{"exercise_price":8.22,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":4869},"source":{"system":"sec-edgar","filing":"0001104659-22-029266","document":"tm228148-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922029266/tm228148-1_4seq1.xml","form_type":"4"}},{"id":2359189,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-03-02T21:05:45.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":10041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on August 21, 2021."}],"balance_after":130556,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":10041},"source":{"system":"sec-edgar","filing":"0001104659-22-029266","document":"tm228148-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922029266/tm228148-1_4seq1.xml","form_type":"4"}},{"id":2359188,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:05:45.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":4869,"price":40.0406,"value":194957.6814,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.74 to $40.39. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-029266","document":"tm228148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922029266/tm228148-1_4seq1.xml","form_type":"4"}},{"id":2359187,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:05:45.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":4869,"price":8.22,"value":40023.18,"ownership":{"direct":true},"balance_after":4869,"source":{"system":"sec-edgar","filing":"0001104659-22-029266","document":"tm228148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922029266/tm228148-1_4seq1.xml","form_type":"4"}},{"id":2359186,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:05:45.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":10041,"price":40.0013,"value":401653.0533,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.06. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-029266","document":"tm228148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922029266/tm228148-1_4seq1.xml","form_type":"4"}},{"id":2359185,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:05:45.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":10041,"price":24,"value":240984.0,"ownership":{"direct":true},"balance_after":10041,"source":{"system":"sec-edgar","filing":"0001104659-22-029266","document":"tm228148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922029266/tm228148-1_4seq1.xml","form_type":"4"}},{"id":2384631,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-02-18T21:05:59.000Z","date":"2022-02-17","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on August 21, 2021."}],"balance_after":140397,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001104659-22-025148","document":"tm227120-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922025148/tm227120-1_4seq1.xml","form_type":"4"}},{"id":2384630,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-02-18T21:05:59.000Z","date":"2022-02-16","kind":"exercise","acquired":false,"shares":4259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on August 21, 2021."}],"balance_after":140597,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":4259},"source":{"system":"sec-edgar","filing":"0001104659-22-025148","document":"tm227120-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922025148/tm227120-1_4seq1.xml","form_type":"4"}},{"id":2384629,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:05:59.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":4259,"price":40.015,"value":170423.885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.02. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-025148","document":"tm227120-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922025148/tm227120-1_4seq1.xml","form_type":"4"}},{"id":2384628,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:05:59.000Z","date":"2022-02-17","kind":"exercise","acquired":true,"shares":200,"price":24,"value":4800.0,"ownership":{"direct":true},"balance_after":200,"source":{"system":"sec-edgar","filing":"0001104659-22-025148","document":"tm227120-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922025148/tm227120-1_4seq1.xml","form_type":"4"}},{"id":2384627,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:05:59.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":4259,"price":40.0542,"value":170590.8378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.21. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-025148","document":"tm227120-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922025148/tm227120-1_4seq1.xml","form_type":"4"}},{"id":2384626,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:05:59.000Z","date":"2022-02-16","kind":"exercise","acquired":true,"shares":4259,"price":24,"value":102216.0,"ownership":{"direct":true},"balance_after":4259,"source":{"system":"sec-edgar","filing":"0001104659-22-025148","document":"tm227120-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922025148/tm227120-1_4seq1.xml","form_type":"4"}},{"id":2438605,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-01-10T21:07:48.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":2435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is currently vested with respect to 0 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 1, 2022."}],"balance_after":4869,"derivative":{"exercise_price":8.22,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":2435},"source":{"system":"sec-edgar","filing":"0001104659-22-002722","document":"tm221863-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922002722/tm221863-2_4seq1.xml","form_type":"4"}},{"id":2438604,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2022-01-10T21:07:48.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":3690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is currently vested with respect to 0 shares, and will vest with respect to the remainder of the shares on October 1, 2022."}],"balance_after":9739,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":3690},"source":{"system":"sec-edgar","filing":"0001104659-22-002722","document":"tm221863-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922002722/tm221863-2_4seq1.xml","form_type":"4"}},{"id":2438603,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-10T21:07:48.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":424,"price":41.2309,"value":17481.9016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.08 to $41.39. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-002722","document":"tm221863-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922002722/tm221863-2_4seq1.xml","form_type":"4"}},{"id":2438602,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-10T21:07:48.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":4302,"price":40.5345,"value":174379.419,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.07 to $41.02. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":424,"source":{"system":"sec-edgar","filing":"0001104659-22-002722","document":"tm221863-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922002722/tm221863-2_4seq1.xml","form_type":"4"}},{"id":2438601,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-10T21:07:48.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":1399,"price":39.5972,"value":55396.4828,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.05 to $40.04. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4726,"source":{"system":"sec-edgar","filing":"0001104659-22-002722","document":"tm221863-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922002722/tm221863-2_4seq1.xml","form_type":"4"}},{"id":2438600,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-10T21:07:48.000Z","date":"2022-01-06","kind":"exercise","acquired":true,"shares":6125,"price":8.22,"value":50347.5,"ownership":{"direct":true},"balance_after":6125,"source":{"system":"sec-edgar","filing":"0001104659-22-002722","document":"tm221863-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922002722/tm221863-2_4seq1.xml","form_type":"4"}},{"id":2525526,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2021-11-03T20:45:19.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is currently vested with respect to 0 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022."}],"balance_after":19476,"derivative":{"exercise_price":8.22,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0000899243-21-042746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321042746/doc4.xml","form_type":"4"}},{"id":2525525,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2021-11-03T20:45:19.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":6048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 3,690 shares, and will vest with respect to the remainder of the shares on October 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Reflects 785 additional stock options which were erroneously reported as exercised on the Form 4 filed by the reporting person on September 3, 2021, but which were actually exercised from the tranche which expires on October 1, 2028."}],"balance_after":13429,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":6048},"source":{"system":"sec-edgar","filing":"0000899243-21-042746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321042746/doc4.xml","form_type":"4"}},{"id":2525524,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-03T20:45:19.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":2946,"price":42.4355,"value":125014.983,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.03 to $43.00. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-042746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321042746/doc4.xml","form_type":"4"}},{"id":2525523,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-03T20:45:19.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":7054,"price":41.3559,"value":291724.5186,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.03 to $42.02. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2946,"source":{"system":"sec-edgar","filing":"0000899243-21-042746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321042746/doc4.xml","form_type":"4"}},{"id":2525522,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-03T20:45:19.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":10000,"price":8.22,"value":82200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-042746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321042746/doc4.xml","form_type":"4"}},{"id":2574263,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2021-09-10T01:34:50.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is currently vested with respect to 4,869 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022."}],"balance_after":23428,"derivative":{"exercise_price":8.22,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":917},"source":{"system":"sec-edgar","filing":"0000899243-21-035508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035508/doc4.xml","form_type":"4"}},{"id":2574262,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2021-09-10T01:34:50.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":4083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is currently vested with respect to 4,868 shares, and will vest with respect to the remainder of the shares in three equal annual installments beginning on October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the exercise of 785 stock options on September 1, 2021, which was reported on the Form 4 filed by the reporting person on September 3, 2021, but erroneously reflected as an exercise of the tranche which expires on October 2, 2027, rather than the tranche which expires on October 1, 2028."}],"balance_after":7304,"derivative":{"exercise_price":8.22,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":4083},"source":{"system":"sec-edgar","filing":"0000899243-21-035508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035508/doc4.xml","form_type":"4"}},{"id":2574261,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-10T01:34:50.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":5000,"price":37,"value":185000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-035508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035508/doc4.xml","form_type":"4"}},{"id":2574260,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-10T01:34:50.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":5000,"price":8.22,"value":41100.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-21-035508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035508/doc4.xml","form_type":"4"}},{"id":2578243,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2021-09-03T20:32:22.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 20,707 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 2, 2021."}],"balance_after":18692,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-035132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035132/doc4.xml","form_type":"4"}},{"id":2578242,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:32:22.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":3302,"price":34.2566,"value":113115.2932,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 33.95 to $34.69. The reporting person undertakes to provide the issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-035132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035132/doc4.xml","form_type":"4"}},{"id":2578241,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:32:22.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":6698,"price":33.295,"value":223009.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.90 to $33.63. The reporting person undertakes to provide the issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3302,"source":{"system":"sec-edgar","filing":"0000899243-21-035132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035132/doc4.xml","form_type":"4"}},{"id":2578240,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:32:22.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":10000,"price":8.22,"value":82200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-035132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035132/doc4.xml","form_type":"4"}},{"id":2586128,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2021-08-30T20:30:20.000Z","date":"2021-08-27","kind":"exercise","acquired":false,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 20,707 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 2, 2021."}],"balance_after":28692,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0000899243-21-034515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321034515/doc4.xml","form_type":"4"}},{"id":2586127,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":82340,"kind":"person","name":"Dierks Jeffrey","position":1,"cik":"0001821102","reported_name":"Dierks Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2021-08-30T20:30:20.000Z","date":"2021-08-26","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 20,707 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 2, 2021."}],"balance_after":32092,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0000899243-21-034515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321034515/doc4.xml","form_type":"4"}}],"next_cursor":"2021-08-30T20:30:20.000000Z,2586127"}